{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:47:01Z","timestamp":1782560821863,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["863795"],"award-info":[{"award-number":["863795"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["14\/IA\/2884"],"award-info":[{"award-number":["14\/IA\/2884"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bonr.2026.101915","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:31:34Z","timestamp":1775579494000},"page":"101915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: A pilot study"],"prefix":"10.1016","volume":"29","author":[{"given":"Syeda Masooma","family":"Naqvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahaaj","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Alberto","family":"Panadero-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schiavi-Tritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laoise M.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2026.101915_bb0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bone.2015.09.010","article-title":"Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia","volume":"81","author":"Achiou","year":"2015","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bonr.2026.101915_bb0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12860-020-00322-w","article-title":"Scl-ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes","volume":"21","author":"Allison","year":"2020","journal-title":"BMC Molecular and Cell Biology"},{"issue":"5","key":"10.1016\/j.bonr.2026.101915_bb0015","first-page":"C969","article-title":"Inhibition of osteoclastogenesis by mechanically stimulated osteoblasts is attenuated during estrogen deficiency","volume":"317","author":"Allison","year":"2019","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.bonr.2026.101915_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bonr.2022.101590","article-title":"Temporal changes in cortical microporosity during estrogen deficiency associated with perilacunar resorption and osteocyte apoptosis: a pilot study","volume":"16","author":"Allison","year":"2022","journal-title":"Bone Reports"},{"issue":"4","key":"10.1016\/j.bonr.2026.101915_bb0025","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bone.2009.11.032","article-title":"Time sequence of secondary mineralization and microhardness in cortical and cancellous bone from ewes","volume":"46","author":"Bala","year":"2010","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bonr.2026.101915_bb0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jbmr.4238","article-title":"Sclerostin antibody administration increases the numbers of Sox9creER+ skeletal precursors and their progeny","volume":"36","author":"Balani","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bonr.2026.101915_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101915_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bonr.2018.03.001","article-title":"Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody","volume":"8","author":"Boyce","year":"2018","journal-title":"Bone Rep"},{"issue":"8","key":"10.1016\/j.bonr.2026.101915_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0033-1363265","article-title":"Estrogen withdrawal from osteoblasts and osteocytes causes increased mineralization and apoptosis","volume":"46","author":"Brennan","year":"2014","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bonr.2026.101915_bb0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2013.11.026","article-title":"Ovariectomy enhances mechanical load-induced solute transport around osteocytes in rat cancellous bone","volume":"59","author":"Ciani","year":"2014","journal-title":"Bone"},{"issue":"16","key":"10.1016\/j.bonr.2026.101915_bb0055","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2026.101915_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115918","article-title":"Sclerostin antibody increases trabecular bone and bone mechanical properties by increasing osteoblast activity damaged by whole-body irradiation in mice","volume":"147","author":"Costa","year":"2021","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bonr.2026.101915_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1074\/jbc.M116.764761","article-title":"Inactivation of regulatory-associated protein of mTOR (raptor)\/mammalian target of rapamycin complex 1 (mTORC1) signaling in osteoclasts increases bone mass by inhibiting osteoclast differentiation in mice*","volume":"292","author":"Dai","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bonr.2026.101915_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00433","article-title":"Cathepsin k: the action in and beyond bone","volume":"8","author":"Dai","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.bonr.2026.101915_bb0075","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1096\/fj.201601280R","article-title":"Estrogen deficiency attenuates fluid flow-induced [Ca2+]i oscillations and mechanoresponsiveness of MLO-Y4 osteocytes","volume":"31","author":"Deepak","year":"2017","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.bonr.2026.101915_bb0080","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.celrep.2017.10.115","article-title":"Osteocyte-intrinsic TGF-\u03b2 signaling regulates bone quality through Perilacunar\/Canalicular remodeling","volume":"21","author":"Dole","year":"2017","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bonr.2026.101915_bb0085","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bone.2009.11.006","article-title":"Osteocyte apoptosis and control of bone resorption following ovariectomy in mice","volume":"46","author":"Emerton","year":"2010","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bonr.2026.101915_bb0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.3001","article-title":"Osteocyte-secreted Wnt signaling inhibitor Sclerostin contributes to beige Adipogenesis in peripheral fat depots","volume":"32","author":"Fulzele","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bonr.2026.101915_bb0095","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1038\/s41598-019-41095-3","article-title":"Estrogen deficiency impairs integrin \u03b1v\u03b23-mediated mechanosensation by osteocytes and alters osteoclastogenic paracrine signalling","volume":"9","author":"Geoghegan","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bonr.2026.101915_bb0100","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1074\/jbc.M112.437921","article-title":"Crosstalk between caveolin-1\/extracellular signal-regulated kinase (ERK) and \u03b2-catenin survival pathways in osteocyte mechanotransduction","volume":"288","author":"Gortazar","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bonr.2026.101915_bb0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bonr.2026.101915_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2017.11.003","article-title":"Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists","volume":"107","author":"Holdsworth","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101915_bb0115","article-title":"Osteocyte Wnt\/\u03b2-catenin pathway activation upon mechanical loading is altered in ovariectomized mice","volume":"15","author":"Jackson","year":"2021","journal-title":"Bone Rep"},{"issue":"211","key":"10.1016\/j.bonr.2026.101915_bb0120","doi-asserted-by":"crossref","first-page":"211ra158","DOI":"10.1126\/scitranslmed.3006627","article-title":"Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome","volume":"5","author":"Kedlaya","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.bonr.2026.101915_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","article-title":"Regulation of NFATc1 in osteoclast differentiation","volume":"21","author":"Kim","year":"2014","journal-title":"J Bone Metab"},{"issue":"5","key":"10.1016\/j.bonr.2026.101915_bb0130","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jbmr.3038","article-title":"Sclerostin antibody administration converts bone lining cells into active osteoblasts","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bonr.2026.101915_bb0135","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/jbmr.2003","article-title":"Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2","volume":"28","author":"Kogawa","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bonr.2026.101915_bb0140","first-page":"C53","article-title":"Recombinant sclerostin antagonizes effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size","volume":"314","author":"Kogawa","year":"2018","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"12","key":"10.1016\/j.bonr.2026.101915_bb0145","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.01428-09","article-title":"Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis","volume":"30","author":"Kramer","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"20","key":"10.1016\/j.bonr.2026.101915_bb0150","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bonr.2026.101915_bb0155","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bonr.2026.101915_bb0160","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1210\/en.2013-1905","article-title":"Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody","volume":"155","author":"Li","year":"2014","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bonr.2026.101915_bb0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bonr.2026.101915_bb0170","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/jbmr.3452","article-title":"Effects of 24 months of treatment with Romosozumab followed by 12 months of Denosumab or placebo in postmenopausal women with low bone mineral density: a randomized, double-blind, phase 2, parallel group study","volume":"33","author":"McClung","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101915_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115967","article-title":"Osteocyte mechanosensing following short-term and long-term treatment with sclerostin antibody","volume":"149","author":"Morrell","year":"2021","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bonr.2026.101915_bb0180","doi-asserted-by":"crossref","first-page":"ziae098","DOI":"10.1093\/jbmrpl\/ziae098","article-title":"Altered extracellular matrix and mechanotransduction gene expression in rat bone tissue following long-term estrogen deficiency","volume":"8","author":"Naqvi","year":"2024","journal-title":"JBMR Plus"},{"issue":"8","key":"10.1016\/j.bonr.2026.101915_bb0185","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/jbmr.2482","article-title":"Transcriptional profiling of laser capture microdissected subpopulations of the osteoblast lineage provides insight into the early response to Sclerostin antibody in rats","volume":"30","author":"Nioi","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bonr.2026.101915_bb0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00223-017-0243-x","article-title":"Advanced glycation end product 3 (AGE3) increases apoptosis and the expression of Sclerostin by stimulating TGF-\u03b2 expression and secretion in osteocyte-like MLO-Y4-A2 cells","volume":"100","author":"Notsu","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bonr.2026.101915_bb0195","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","article-title":"Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength","volume":"25","author":"Ominsky","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101915_bb0200","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bone.2015.08.007","article-title":"Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats","volume":"81","author":"Ominsky","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101915_bb0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bone.2016.10.019","article-title":"Effects of sclerostin antibodies in animal models of osteoporosis","volume":"96","author":"Ominsky","year":"2017","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bonr.2026.101915_bb0210","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jbmr.3036","article-title":"Romosozumab improves bone mass and strength while maintaining bone quality in Ovariectomized Cynomolgus monkeys","volume":"32","author":"Ominsky","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bonr.2026.101915_bb0215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00198-019-05239-5","article-title":"Secondary alterations in bone mineralisation and trabecular thickening occur after long-term estrogen deficiency in ovariectomised rat tibiae, which do not coincide with initial rapid bone loss","volume":"31","author":"O\u2019Sullivan","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bonr.2026.101915_bb0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bonr.2026.101915_bb0225","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.239","article-title":"Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study","volume":"54","author":"Padhi","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bonr.2026.101915_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10253","article-title":"Bone mineral is more heterogeneously distributed in the femoral heads of osteoporotic and diabetic patients: a pilot study","volume":"4","author":"Parle","year":"2020","journal-title":"JBMR Plus"},{"issue":"7","key":"10.1016\/j.bonr.2026.101915_bb0235","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.2188","article-title":"Bone matrix quality after sclerostin antibody treatment","volume":"29","author":"Ross","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"15","key":"10.1016\/j.bonr.2026.101915_bb0240","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bonr.2026.101915_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112005","article-title":"Alterations in osteocyte mediated osteoclastogenesis during estrogen deficiency and under ROCK-II inhibition: an in vitro study using a novel postmenopausal multicellular niche model","volume":"392","author":"Simfia","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.bonr.2026.101915_bb0250","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1210\/jc.2009-0659","article-title":"Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause","volume":"95","author":"Sowers","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bonr.2026.101915_bb0255","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/s41467-018-04679-7","article-title":"Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin","volume":"9","author":"Stegen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bonr.2026.101915_bb0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bone.2014.07.031","article-title":"Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats","volume":"67","author":"Stolina","year":"2014","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bonr.2026.101915_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10377","article-title":"Gene expression profile and acute gene expression response to Sclerostin inhibition in osteogenesis imperfecta bone","volume":"4","author":"Surowiec","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bonr.2026.101915_bb0270","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2015.12.013","article-title":"Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats","volume":"84","author":"Taylor","year":"2016","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bonr.2026.101915_bb0275","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1359\/jbmr.1998.13.8.1243","article-title":"The role of estrogen in the control of rat osteocyte apoptosis","volume":"13","author":"Tomkinson","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bonr.2026.101915_bb0280","doi-asserted-by":"crossref","first-page":"E478","DOI":"10.1073\/pnas.1409857112","article-title":"Osteocytes mediate the anabolic actions of canonical Wnt\/beta-catenin signaling in bone","volume":"112","author":"Tu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bonr.2026.101915_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104697","article-title":"Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture","volume":"115","author":"Turk","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"7","key":"10.1016\/j.bonr.2026.101915_bb0290","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bpj.2015.02.031","article-title":"Altered mechanical environment of bone cells in an animal model of short- and long-term osteoporosis","volume":"108","author":"Verbruggen","year":"2015","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.bonr.2026.101915_bb0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2106\/JBJS.N.00654","article-title":"Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis","volume":"97","author":"Virdi","year":"2015","journal-title":"J. Bone Joint Surg. Am."},{"issue":"5","key":"10.1016\/j.bonr.2026.101915_bb0300","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s00391-017-1219-1","article-title":"The effects of sclerostin antibody plus parathyroid hormone (1-34) on bone formation in ovariectomized rats","volume":"51","author":"Wu","year":"2018","journal-title":"Z. Gerontol. Geriatr."},{"key":"10.1016\/j.bonr.2026.101915_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2021.06.074","article-title":"Effects of advanced glycation end products on osteocytes mechanosensitivity","volume":"568","author":"Yang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bonr.2026.101915_bb0310","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bone.2016.02.005","article-title":"Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse","volume":"87","author":"Zhang","year":"2016","journal-title":"Bone"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:28:26Z","timestamp":1782559706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187226000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"alternative-id":["S2352187226000197"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101915","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.02.616263","asserted-by":"object"}]},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101915"}}